Future studies need to investigate the role of MGMT as a molecular target for sensitizing GBM cells to PRIMA-1MET and whether PRIMA-1MET may effectively sensitize GSCs to TMZ by decreasing MGMT protein levels. This evidence concerns the gene MGMT and glioblastoma.